Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches.

[1]  T. Ikezu,et al.  Mitochondrial extracellular vesicles, autoimmunity and myocarditis , 2024, Frontiers in immunology.

[2]  Á. Fehér,et al.  Geroscience and pathology: a new frontier in understanding age-related diseases , 2024, Pathology oncology research : POR.

[3]  A. Laffan,et al.  Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment , 2024, Nature neuroscience.

[4]  C. Giaginis,et al.  Clinical Evidence on the Potential Beneficial Effects of Diet and Dietary Supplements against COVID-19 Infection Risk and Symptoms’ Severity , 2024, Medical Science.

[5]  J. Bergmann,et al.  Reduced health-related quality of life, fatigue, anxiety and depression affect COVID-19 patients in the long-term after chronic critical illness , 2024, Scientific reports.

[6]  R. Cano-de-la-Cuerda,et al.  Effects of Aerobic Exercise Therapy through Nordic Walking Program in Lactate Concentrations, Fatigue and Quality-of-Life in Patients with Long-COVID Syndrome: A Non-Randomized Parallel Controlled Trial , 2024, Journal of clinical medicine.

[7]  Yu-Yu Chang,et al.  Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage , 2024, PLoS ONE.

[8]  D. Bizjak,et al.  Functional and Morphological Differences of Muscle Mitochondria in Chronic Fatigue Syndrome and Post-COVID Syndrome , 2024, International journal of molecular sciences.

[9]  S. Shahbaz,et al.  Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome , 2024, Frontiers in immunology.

[10]  J. Castro-Marrero,et al.  Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview , 2024, International journal of molecular sciences.

[11]  T. Kanekura,et al.  Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis , 2023, Frontiers in Immunology.

[12]  W. Tate,et al.  A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome , 2023, Scientific reports.

[13]  L. Al Saikhan,et al.  Mechanisms underlying exercise intolerance in long COVID: An accumulation of multisystem dysfunction , 2023, medRxiv.

[14]  N. Veronese,et al.  Incidence and burden of long COVID in Africa: a systematic review and meta-analysis , 2023, Scientific reports.

[15]  J. Hodosy,et al.  Mitochondrial DNA variability and Covid-19 in the Slovak population. , 2023, Mitochondrion (Amsterdam. Print).

[16]  Nandini Bhattacharjee,et al.  Beyond the acute illness: Exploring long COVID and its impact on multiple organ systems. , 2023, Physiology international.

[17]  D. Kondziella,et al.  SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study , 2023, Brain Communications.

[18]  Sang-Won Lee,et al.  Prevalence, clinical significance, and persistence of autoantibodies in COVID-19 , 2023, Virology Journal.

[19]  Marie Mclaughlin,et al.  People With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function. , 2023, American Journal of Medicine.

[20]  A. Vezzoli,et al.  Hyperbaric Oxygen Therapy Counters Oxidative Stress/Inflammation-Driven Symptoms in Long COVID-19 Patients: Preliminary Outcomes , 2023, Metabolites.

[21]  V. R. dos Santos,et al.  Mild to moderate post-COVID-19 alters markers of lymphocyte activation, exhaustion, and immunometabolic responses that can be partially associated by physical activity level— an observational sub-analysis fit- COVID study , 2023, Frontiers in immunology.

[22]  S. Mehta,et al.  Physical health and mental fatigue disability associated with long-COVID: Baseline results from a US nationwide cohort. , 2023, The American journal of medicine.

[23]  U. Stervbo,et al.  INTRAVENOUS IMMUNOGLOBULINS LEAD TO FUNCTIONAL VASCULAR AMELIORATION IN LONG-COVID , 2023, Autoimmunity reviews.

[24]  H. Ochs,et al.  Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach , 2023, npj aging.

[25]  J. Tsai,et al.  Incidence of long COVID and associated psychosocial characteristics in a large U.S. city , 2023, Social Psychiatry and Psychiatric Epidemiology.

[26]  Ping-yuan Wang,et al.  WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Muhammad G. Saleh,et al.  Neuronal and Glial Metabolite Abnormalities in Participants with Persistent Neuropsychiatric Symptoms After COVID-19: A Brain Proton MR Spectroscopy Study. , 2023, The Journal of infectious diseases.

[28]  F. Klawonn,et al.  Amino acids, post-translational modifications, nitric oxide, and oxidative stress in serum and urine of long COVID and ex COVID human subjects , 2023, Amino Acids.

[29]  G. Leipnitz,et al.  Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats , 2023, Journal of NeuroVirology.

[30]  N. Todorović,et al.  Reduced tissue creatine levels in patients with long COVID-19: A cross-sectional study , 2023, Journal of Postgraduate Medicine.

[31]  Tsung-Hsien Chen,et al.  Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder , 2023, International journal of molecular sciences.

[32]  J. Bradbury,et al.  Nutritional Support During Long COVID: A Systematic Scoping Review. , 2023, Journal of integrative and complementary medicine.

[33]  M. Bonafede,et al.  Long COVID Incidence in a Large US Ambulatory Electronic Health Record System. , 2023, American Journal of Epidemiology.

[34]  C. D. dos Santos,et al.  Mitochondria and cytochrome components released into the plasma of severe COVID-19 and ICU acute respiratory distress syndrome patients , 2023, Clinical Proteomics.

[35]  F. Taghizadeh-Hesary,et al.  COVID-19 induced liver injury from a new perspective: Mitochondria , 2023, Mitochondrion.

[36]  K. Stronks,et al.  Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study , 2023, The Lancet Regional Health - Europe.

[37]  J. Pradines,et al.  Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study , 2023, eClinicalMedicine.

[38]  Yan Xie,et al.  Long-term gastrointestinal outcomes of COVID-19 , 2023, Nature Communications.

[39]  V. Kanamarlapudi,et al.  Molecular Analysis of SARS-CoV-2 Spike Protein-Induced Endothelial Cell Permeability and vWF Secretion , 2023, International journal of molecular sciences.

[40]  J. Stuart,et al.  Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-κB Non-Canonical Pathway and Mitochondrial Remodeling , 2023, Viruses.

[41]  J. Berlanga-Acosta,et al.  Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis , 2023, Archives of Virology.

[42]  R. Shafer,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic , 2023, Frontiers in Neurology.

[43]  A. Angelova,et al.  Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome , 2023, Antioxidants.

[44]  M. Jacobs,et al.  Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19 , 2023, Journal of the National Medical Association.

[45]  C. S. Kow,et al.  Coenzyme Q10 therapy in patients with post COVID-19 condition , 2023, The Lancet Regional Health - Europe.

[46]  A. M. van der Bliek,et al.  Exercise preserves physical fitness during aging through AMPK and mitochondrial dynamics , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[47]  V. Versace,et al.  Long-COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Potential neurophysiological biomarkers for these enigmatic entities , 2023, Clinical Neurophysiology.

[48]  K. Thangaraj,et al.  Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications , 2023, Mitochondrion.

[49]  T. Glasz,et al.  Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsies , 2022, GeroScience.

[50]  M. Sack.  Tackling Inflammation at its Source in Heart Failure , 2022, JACC: Basic to Translational Science.

[51]  S. Sayyab,et al.  Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells , 2022, Clinical epigenetics.

[52]  O. Bruyère,et al.  Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients , 2022, Internal and Emergency Medicine.

[53]  R. Qaisar,et al.  Elevated plasma CAF22 are incompletely restored six months after COVID-19 infection in older men , 2022, Experimental Gerontology.

[54]  Irwin Jungreis,et al.  The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity , 2022, bioRxiv.

[55]  T. Mogensen,et al.  High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial , 2022, The Lancet Regional Health - Europe.

[56]  Rudranil De,et al.  Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight , 2022, Molecular and Cellular Biochemistry.

[57]  I. Stefanidis,et al.  Genetics of COVID‐19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review , 2022, Annals of clinical and translational neurology.

[58]  G. Blandino,et al.  Opposite Effect of Thyroid Hormones on Oxidative Stress and on Mitochondrial Respiration in COVID-19 Patients , 2022, Antioxidants.

[59]  D. Falzarano,et al.  SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia , 2022, Redox Biology.

[60]  N. Speybroeck,et al.  Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016–2020) , 2022, BMC Infectious Diseases.

[61]  F. Paulus,et al.  Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity , 2022, Frontiers in Immunology.

[62]  A. Borbély,et al.  The majority of severe COVID-19 patients develop anti-cardiac autoantibodies , 2022, GeroScience.

[63]  P. Kellman,et al.  Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case–control study , 2022, Journal of Cardiovascular Magnetic Resonance.

[64]  S. Ong,et al.  Long COVID-19 and the heart: is cardiac mitochondria the missing link? , 2022, Antioxidants & redox signaling.

[65]  B. Trimarco,et al.  Targeting endothelial dysfunction and oxidative stress in Long-COVID , 2022, Pharmacological Research.

[66]  Manuel F. Navedo,et al.  Disruption of mitochondria–sarcoplasmic reticulum microdomain connectomics contributes to sinus node dysfunction in heart failure , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[67]  F. Bianchi,et al.  Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome , 2022, Clinical and Experimental Medicine.

[68]  Shuangnian Xu,et al.  COVID‐19 metabolism: Mechanisms and therapeutic targets , 2022, MedComm.

[69]  A. Mammen,et al.  Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries , 2022, Nature Biomedical Engineering.

[70]  H. Endeman,et al.  In Vivo and Ex Vivo Mitochondrial Function in COVID-19 Patients on the Intensive Care Unit , 2022, Biomedicines.

[71]  Huanchun Chen,et al.  SARS-CoV-2 productively infects human brain microvascular endothelial cells , 2022, Journal of neuroinflammation.

[72]  Boli Zhang,et al.  The Long-Term Effect of COVID-19 Disease Severity on Risk of Diabetes Incidence and the Near 1-Year Follow-Up Outcomes among Postdischarge Patients in Wuhan , 2022, Journal of clinical medicine.

[73]  G. Domján,et al.  COVID-19 and the elderly. , 2022, Physiology international.

[74]  Á. Fehér,et al.  Comorbidities and increased mortality of COVID-19 among the elderly: A systematic review. , 2022, Physiology international.

[75]  K. Kraft,et al.  Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C , 2022, Frontiers in Pharmacology.

[76]  Jamie B. Spangler,et al.  IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function , 2022, JCI insight.

[77]  Oscar J. Pellicer-Valero,et al.  Exploring the recovery curve for gastrointestinal symptoms from the acute COVID‐19 phase to long‐term post‐COVID: The LONG‐COVID‐EXP‐CM Multicenter Study , 2022, Journal of medical virology.

[78]  J. Silverberg,et al.  Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity , 2022, Nature Communications.

[79]  R. Ryback,et al.  Mitochondria, a Missing Link in COVID-19 Heart Failure and Arrest? , 2022, Frontiers in Cardiovascular Medicine.

[80]  M. Martinez-Fierro,et al.  Peripheral Blood Mitochondrial DNA Levels Were Modulated by SARS-CoV-2 Infection Severity and Its Lessening Was Associated With Mortality Among Hospitalized Patients With COVID-19 , 2021, Frontiers in Cellular and Infection Microbiology.

[81]  C. Gramaglia,et al.  Association Between Plasma Redox State/Mitochondria Function and a Flu-Like Syndrome/COVID-19 in the Elderly Admitted to a Long-Term Care Unit , 2021, Frontiers in Physiology.

[82]  Roya Vaziri-harami,et al.  Can l-carnitine reduce post-COVID-19 fatigue? , 2021, Annals of Medicine and Surgery.

[83]  Hongbin He,et al.  SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy , 2021, Cellular & Molecular Immunology.

[84]  D. Mishmar,et al.  Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis , 2021, iScience.

[85]  H. Busch,et al.  The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells , 2021, Nature Neuroscience.

[86]  M. Brodmann,et al.  Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection—A Cross-Sectional Study , 2021, Frontiers in Cardiovascular Medicine.

[87]  A. Buki,et al.  Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms , 2021, Journal of clinical medicine.

[88]  S. Wu,et al.  Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients , 2021, Antioxidants.

[89]  M. Martinez-Fierro,et al.  Mitochondria and Mitochondrial DNA: Key Elements in the Pathogenesis and Exacerbation of the Inflammatory State Caused by COVID-19 , 2021, Medicina.

[90]  S. Snyder,et al.  Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome , 2021, Proceedings of the National Academy of Sciences.

[91]  M. Suntsova,et al.  COVID-19–associated inhibition of energy accumulation pathways in human semen samples , 2021, F&S Science.

[92]  L. Dölken,et al.  SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro , 2021, Frontiers in Cellular and Infection Microbiology.

[93]  C. Dieterich,et al.  Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants , 2021, Basic Research in Cardiology.

[94]  O. Smirnova,et al.  Peroxiredoxins—The Underrated Actors during Virus-Induced Oxidative Stress , 2021, Antioxidants.

[95]  M. Spraul,et al.  Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome , 2021, Journal of proteome research.

[96]  B. Natelson,et al.  Exosome‐associated mitochondrial DNA from patients with myalgic encephalomyelitis/chronic fatigue syndrome stimulates human microglia to release IL‐1β , 2021, The European journal of neuroscience.

[97]  F. Müller,et al.  The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2 , 2021, Stem Cell Reports.

[98]  N. Lukacs,et al.  Role of Mitochondria in Viral Infections , 2021, Life.

[99]  S. Holden,et al.  A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome , 2021, Journal of translational medicine.

[100]  A. Pandey,et al.  Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target? , 2021, Molecular Biomedicine.

[101]  W. Heywood,et al.  ‘The long tail of Covid-19’ - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients , 2021, F1000Research.

[102]  L. Joosten,et al.  Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome , 2020, Journal of Translational Medicine.

[103]  E. Wood,et al.  Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’? , 2020, Chronic Diseases and Translational Medicine.

[104]  B. Chernyak,et al.  Mitochondria as Targets for Endothelial Protection in COVID-19 , 2020, Frontiers in Physiology.

[105]  Elias Myrstad Brodwall,et al.  Pain in adolescent chronic fatigue following Epstein-Barr virus infection , 2020, Scandinavian journal of pain.

[106]  Piyali Mukherjee,et al.  Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses , 2020, Frontiers in Microbiology.

[107]  T. Kleffmann,et al.  A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction , 2020, Journal of translational medicine.

[108]  D. Kreisel,et al.  Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19 , 2020, bioRxiv.

[109]  D. Staines,et al.  A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease , 2020, Journal of Translational Medicine.

[110]  Gayathri Krishna,et al.  Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein–Barr Virus Infected Cells , 2020, Viruses.

[111]  G. Chaubey,et al.  Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis , 2020, American journal of physiology. Cell physiology.

[112]  P. Morbini,et al.  Direct endothelial damage and vasculitis due to SARS‐CoV‐2 in small bowel submucosa of COVID‐19 patient with diarrhea , 2020, Journal of medical virology.

[113]  M. Endres,et al.  The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 , 2020, European Respiratory Journal.

[114]  C. Gottfries,et al.  Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies , 2020, Frontiers in Medicine.

[115]  T. Kiss,et al.  Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects , 2020, GeroScience.

[116]  Cory B. Giles,et al.  Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects , 2019, GeroScience.

[117]  T. Kiss,et al.  Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment , 2019, GeroScience.

[118]  L. Joosten,et al.  A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome , 2019, Journal of Translational Medicine.

[119]  T. Kiss,et al.  Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice , 2019, Redox biology.

[120]  E. Skovlund,et al.  Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study , 2019, Brain, Behavior, and Immunity.

[121]  P. Rabinovitch,et al.  Treatment with the mitochondrial‐targeted antioxidant peptide SS‐31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice , 2018, Aging cell.

[122]  J. Baur,et al.  NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. , 2017, Cell metabolism.

[123]  A. Keinan,et al.  Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome , 2016, Journal of Translational Medicine.

[124]  G. Kellermann,et al.  New insights into Lyme disease , 2015, Redox biology.

[125]  U. Wisløff,et al.  Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle , 2015, European journal of heart failure.

[126]  Csaba Szabo,et al.  Endothelial dysfunction is a potential contributor to multiple organ failure and mortality in aged mice subjected to septic shock: preclinical studies in a murine model of cecal ligation and puncture , 2014, Critical Care.

[127]  G. Morris,et al.  Mitochondrial dysfunctions in Myalgic Encephalomyelitis / chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways , 2013, Metabolic Brain Disease.

[128]  J. Marín-García,et al.  Mitochondria in heart failure: the emerging role of mitochondrial dynamics , 2013, Heart Failure Reviews.

[129]  M. Gheorghiade,et al.  Mitochondria as a therapeutic target in heart failure. , 2013, Journal of the American College of Cardiology.

[130]  C. Hoppel,et al.  Mitochondria in cardiac hypertrophy and heart failure. , 2013, Journal of molecular and cellular cardiology.

[131]  Jianfei Xie,et al.  Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach. , 2012, International journal of molecular medicine.

[132]  M. Maes,et al.  Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[133]  Gregory C Kujoth,et al.  Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice , 2011, Proceedings of the National Academy of Sciences.

[134]  C. Hoppel,et al.  Mitochondria in heart failure. , 2010, Cardiovascular research.

[135]  Z. Ungvari,et al.  Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells , 2009, American journal of physiology. Heart and circulatory physiology.

[136]  Z. Ungvari,et al.  The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach. , 2009, The American journal of pathology.

[137]  E. Lakatta,et al.  Inflammation and endothelial dysfunction during aging: role of NF-kappaB. , 2008, Journal of applied physiology.

[138]  Z. Ungvari,et al.  Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats. , 2008, American journal of physiology. Heart and circulatory physiology.

[139]  Z. Ungvari,et al.  Increased mitochondrial H2O2 production promotes endothelial NF-κB activation in aged rat arteries , 2007 .

[140]  J. Speakman,et al.  Exercise by lifelong voluntary wheel running reduces subsarcolemmal and interfibrillar mitochondrial hydrogen peroxide production in the heart. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[141]  D. LaJeunesse,et al.  Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication. , 2005, Biochemical and biophysical research communications.

[142]  A. Navarro,et al.  Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[143]  S. Kawanishi,et al.  Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells. , 2002, Biochemical and biophysical research communications.

[144]  G. Schuler,et al.  Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. , 1997, Journal of the American College of Cardiology.

[145]  S. Wessely,et al.  Development of a fatigue scale. , 1993, Journal of psychosomatic research.

[146]  OUP accepted manuscript , 2021, Cardiovascular Research.

[147]  Fusheng Yu,et al.  Serum peroxiredoxin3 is a useful biomarker for early diagnosis and assessemnt of prognosis of hepatocellular carcinoma in Chinese patients. , 2014, Asian Pacific journal of cancer prevention : APJCP.